MeSH term
Frequency | Condition_Probility | Adult | 3 | 0.0 |
Comparative Study | 10 | 0.0 |
Humans | 93 | 0.0 |
Aged | 2 | 0.0 |
Female | 4 | 0.0 |
Biopsy | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Protein-Tyrosine Kinase/*genetics/metabolism | 3 | 6.0 |
Tumor Cells, Cultured | 10 | 0.0 |
Animals | 39 | 0.0 |
COS Cells | 9 | 0.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Hela Cells | 6 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 5 | 3.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 4 | 1.0 |
Signal Transduction/*physiology | 3 | 0.0 |
*src Homology Domains | 9 | 4.0 |
Cell Line | 23 | 0.0 |
Enzyme Activation | 16 | 0.0 |
Fibroblasts | 3 | 0.0 |
Gene Products, nef/metabolism | 2 | 16.0 |
Phosphorylation | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 33 | 0.0 |
Signal Transduction | 17 | 0.0 |
Spodoptera | 4 | 1.0 |
Structure-Activity Relationship | 5 | 0.0 |
Models, Molecular | 7 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
Nuclear Magnetic Resonance, Biomolecular/methods | 2 | 8.0 |
Protein Binding | 15 | 0.0 |
Research Support, Non-U.S. Gov't | 74 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Kinetics | 6 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Amino Acid Sequence | 24 | 0.0 |
Blotting, Western | 7 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Jurkat Cells | 5 | 0.0 |
Mutation | 6 | 0.0 |
Precipitin Tests | 6 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 6 | 0.0 |
Proto-Oncogene Proteins/metabolism | 6 | 0.0 |
Transfection | 15 | 0.0 |
U937 Cells | 3 | 0.0 |
src Homology Domains | 11 | 1.0 |
src-Family Kinases/chemistry/*metabolism | 2 | 28.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
*Signal Transduction | 4 | 0.0 |
src-Family Kinases/*metabolism | 9 | 5.0 |
Enzyme Inhibitors/pharmacology | 6 | 0.0 |
Mice | 18 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 18 | 2.0 |
Proto-Oncogene Proteins/*metabolism | 17 | 1.0 |
Mice, Transgenic | 2 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 5 | 2.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*chemistry/*metabolism | 2 | 11.0 |
Cell Culture Techniques | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism/physiology | 2 | 13.0 |
Chromosome Banding | 3 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Substrate Specificity | 8 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
Consensus Sequence | 2 | 0.0 |
HIV-1/genetics/*physiology | 2 | 1.0 |
Protein-Tyrosine Kinase/chemistry/genetics/*metabolism | 2 | 8.0 |
Proto-Oncogene Proteins/chemistry/genetics/*metabolism | 2 | 3.0 |
Proto-Oncogenes | 3 | 1.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Chemotaxis, Leukocyte/drug effects/*physiology | 2 | 10.0 |
In Vitro | 4 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Cell Degranulation | 2 | 4.0 |
Protein-Tyrosine Kinase/*physiology | 3 | 2.0 |
Tyrosine/metabolism | 7 | 0.0 |
src-Family Kinases/metabolism | 5 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Male | 5 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Base Sequence | 10 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Catalysis | 5 | 0.0 |
Cells, Cultured | 10 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Acylation | 2 | 2.0 |
Cell Differentiation | 5 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Signal Transduction/immunology | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Cytokines/physiology | 2 | 1.0 |
Ligands | 3 | 0.0 |
Solubility | 3 | 0.0 |
Drug Synergism | 2 | 0.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Quinones/pharmacology | 2 | 1.0 |
Vanadates/pharmacology | 3 | 2.0 |
Proline/chemistry | 2 | 4.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 2 | 5.0 |
Rats | 4 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 3 | 1.0 |
DNA Primers | 4 | 0.0 |
Gene Products, nef/*metabolism | 3 | 11.0 |
HIV-1/*metabolism | 2 | 0.0 |
Gene Products, nef/genetics/*metabolism | 2 | 6.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/*metabolism | 2 | 5.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Biological Transport | 3 | 0.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 2 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Protein-Tyrosine Kinase/genetics | 3 | 2.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Computer Simulation | 2 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
3T3 Cells | 3 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Mercuric Chloride/pharmacology | 2 | 15.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Pyrazoles/pharmacology | 2 | 4.0 |
Pyrimidines/pharmacology | 4 | 3.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Catalytic Domain | 3 | 1.0 |
Monocytes/*physiology | 2 | 1.0 |
Binding Sites | 6 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein-Tyrosine Kinase/*biosynthesis/*genetics | 2 | 40.0 |
Restriction Mapping | 2 | 0.0 |
Zymosan/pharmacology | 2 | 2.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry | 3 | 15.0 |
Proto-Oncogene Proteins/*chemistry | 3 | 14.0 |
Solutions | 2 | 1.0 |
Signal Transduction/physiology | 2 | 0.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
*Gene Expression | 2 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Chickens | 2 | 0.0 |
Peptide Fragments/chemistry | 2 | 1.0 |
*Protein Structure, Secondary | 2 | 1.0 |
Protein-Tyrosine Kinase/*chemistry/*metabolism | 3 | 20.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Calcimycin/pharmacology | 2 | 0.0 |
N-Formylmethionine Leucyl-Phenylalanine/pharmacology | 4 | 1.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 4 | 0.0 |
Tretinoin/pharmacology | 2 | 0.0 |
Recombinant Fusion Proteins/chemistry/genetics/metabolism | 2 | 1.0 |
Genetic Vectors | 3 | 0.0 |
Fusion Proteins, bcr-abl/*metabolism | 2 | 5.0 |
Piperazines/pharmacology | 2 | 1.0 |
Cell Compartmentation | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Cell Division | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Cercopithecus aethiops | 3 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 20 | 2 | 1.0 |
Chromosomes, Human, Pair 20/*ultrastructure | 2 | 50.0 |
Gene Expression | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Vimentin/metabolism | 2 | 1.0 |
